Advanced Medical Solutions (GB:AMS) has released an update.
Advanced Medical Solutions has reported robust interim financial results for H1 2024, with an 8% revenue increase and significant growth in its Surgical business unit, bolstered by strategic acquisitions such as Peters Surgical and Syntacoll. Despite challenges in the Woundcare sector, overall adjusted profits before tax rose by 8%, while the group remains optimistic about continued growth and meeting full-year expectations. The interim dividend has also been hiked by 10%, reflecting the board’s confidence in the company’s trajectory.
For further insights into GB:AMS stock, check out TipRanks’ Stock Analysis page.
